about
Consensus-Based Recommendations on the Definition and Classification of Cholesteatoma[Selected applications of diode laser in laryngological surgery].[CO2 laser treatment of rhinophyma].Etiopathogenesis of cholesteatoma.Clinical assessment of the efficacy of photodynamic therapy in the treatment of oral lichen planusMolecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.Minimally invasive medial maxillectomy and the position of nasolacrimal duct: the CT study.Hexosaminidase as a new potential marker for larynx cancer.EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.Cholesteatoma Definition and Classification: A Literature Review.Assessment and management of retraction pockets.The activity of N-acetyl-β-d-hexosaminidase A and B and β-glucuronidase in nasal polyps and hypertrophic nasal concha.Usefulness of snoreplasty in the treatment of simple snoring and mild obstructive sleep apnea/hypopnea syndrome - Preliminary report.[Epidemiological and demographic analysis of indications for Baha® surgery in Poland--multicenter study].The role of p21 and p53 proteins in congenital cholesteatoma.Fibroblast-Like Synovial Cells in Rheumatoid Arthritis--the Impact of Infliximab on Hexosaminidase Activity.[The influence of endoscopic treatment of isolated, small inflammatory lesions of sphenoid sinus on headache sensation].Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma.Minimally invasive transnasal medial maxillectomy for treatment of maxillary sinus and orbital pathologies.Hexosaminidase as a new potential marker for middle ear cholesteatomaStatistical evaluation of the isoform patterns of N-acetyl-beta-hexosaminidase from human renal cancer tissue separated by isoelectrofocusingIsoenzymes of N-acetyl-beta-hexosaminidase in human pleomorphic adenoma and healthy salivary glands: a preliminary studyCatabolism of glycoconjugates in chronic otitis media with cholesteatomaCytokeratin expression pattern in congenital and acquired pediatric cholesteatomaCholesteatoma-associated pathogenicity: potential role of lysosomal exoglycosidasesIntraoperative bleeding during endoscopic sinus surgery and microvascular density of the nasal mucosa
P50
Q26801744-8CA68EDB-1673-4CFE-8CDA-1E25A2B0FBCDQ33384035-6A621BE6-5FEB-4DCA-B9EB-976FC24AC73FQ33384037-F70AE729-F59E-40D5-80D0-D1B684A3D3CAQ34210244-C0C128FE-99EC-4C83-A2DD-E5B953B15D1CQ34344334-52984D16-B515-4A20-89CD-F805ADDE8180Q35097737-D574C800-A453-4122-A3C0-B1A5EE08D945Q37642142-F8B55E6F-C024-4BF8-948B-ACF623137CF4Q38355756-80DF289A-7E01-48ED-AAB4-1EF33BCD245EQ38774182-AB7DABD0-2E0A-4A95-BF22-FF57CD2615B3Q39169284-CA8F7898-CC66-4961-BBD9-A1CF439871C7Q39293172-29F1C687-D042-4AE2-A183-D5722B499882Q41964438-D3CEC040-8F69-4487-B116-253A40A7799CQ44353126-B30CE46E-FC76-4B74-B9BF-4E7719D4BCFCQ44768107-8C6265B7-5B69-4826-90FE-31119B1FB03BQ53124452-99149D20-4703-49F6-A232-B160C2CCBF0AQ53209135-078EF930-F3E8-4902-86F1-EAD18089EA72Q53276593-1D2CA1FF-48C5-48FF-8C6F-5D81E0527FB0Q53303718-C02B9F83-9813-4660-8983-C4650773510AQ54455403-9A80D661-DB00-4A7B-93AD-FF5AAEA96D89Q79277685-557619FB-B381-4861-836A-A40D5E8DD1B1Q79781047-54F9BB37-EBED-49A7-8525-5285EDD117EAQ79947884-BC65353E-282B-4AC8-BD3A-AF6BA9454F0EQ81239375-3F7FA95B-1085-4F9D-B1BE-F60D0D08484DQ81491457-F5315F50-FB5C-4146-9696-BF2A1D52C477Q84139107-1F36B5B3-C1D8-4AAF-A587-88C88FAE52B6Q87814500-6E9B6374-FB79-4A52-9FD2-37233B84959E
P50
description
researcher ORCID ID = 0000-0002-9993-9266
@en
name
Ewa Olszewska
@ast
Ewa Olszewska
@ca
Ewa Olszewska
@cs
Ewa Olszewska
@en
Ewa Olszewska
@es
Ewa Olszewska
@gl
Ewa Olszewska
@hr
Ewa Olszewska
@hsb
Ewa Olszewska
@it
Ewa Olszewska
@nl
type
label
Ewa Olszewska
@ast
Ewa Olszewska
@ca
Ewa Olszewska
@cs
Ewa Olszewska
@en
Ewa Olszewska
@es
Ewa Olszewska
@gl
Ewa Olszewska
@hr
Ewa Olszewska
@hsb
Ewa Olszewska
@it
Ewa Olszewska
@nl
prefLabel
Ewa Olszewska
@ast
Ewa Olszewska
@ca
Ewa Olszewska
@cs
Ewa Olszewska
@en
Ewa Olszewska
@es
Ewa Olszewska
@gl
Ewa Olszewska
@hr
Ewa Olszewska
@hsb
Ewa Olszewska
@it
Ewa Olszewska
@nl
P214
P1153
7004098722
P1412
P1559
Ewa Olszewska
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-9993-9266
P734
P735
P7859
viaf-315232708